Genetic Ablation of Adamts13 Gene Dramatically Accelerates the Formation of Early Atherosclerosis in a Murine Model

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2012-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1161/ATVBAHA.112.247262PMID 22652598PMCID PMC3422623
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice.

  2012cited by this paper
• The distal carboxyterminal domains of murine ADAMTS13 influence proteolysis of platelet‐decorated VWF strings in vivo

  2010cited by this paper
• von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke.

  2009cited by this paper
• Correction of ADAMTS13 deficiency by in utero gene transfer of lentiviral vector encoding ADAMTS13 genes.

  2009cited by this paper
• P-selectin glycoprotein ligand-1 plays a crucial role in the selective recruitment of leukocytes into the atherosclerotic arterial wall.

  2009cited by this paper
• ADAMTS13: a new link between thrombosis and inflammation

  2008influential reference
• Evidence that high von Willebrand factor and low ADAMTS-13 levels independently increase the risk of a non-fatal heart attack

  2008cited by this paper
• Correction of murine ADAMTS13 deficiency by hematopoietic progenitor cell-mediated gene therapy.

  2008cited by this paper
• Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction.

  2007cited by this paper
• P-selectin glycoprotein ligand 1 and beta2-integrins cooperate in the adhesion of leukocytes to von Willebrand factor.

  2006cited by this paper
• High von Willebrand Factor Levels Increase the Risk of First Ischemic Stroke: Influence of ADAMTS13, Inflammation, and Genetic Variability

  2006cited by this paper
• Reduced von Willebrand factor‐cleaving protease (ADAMTS13) activity in acute myocardial infarction

  2006cited by this paper
• Systemic antithrombotic effects of ADAMTS13

  2006cited by this paper
• Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation

  2005cited by this paper
• Localization of ADAMTS13 to the stellate cells of human liver.

  2005cited by this paper
• Cleavage of ultra‐large von Willebrand factor by ADAMTS‐13 under flow conditions

  2005cited by this paper
• P-selectin Glycoprotein Ligand-1 Mediates L-Selectin–dependent Leukocyte Rolling in Venules

  2003cited by this paper
• ADAMTS-13 Metalloprotease Interacts with the Endothelial Cell-derived Ultra-large von Willebrand Factor*

  2003cited by this paper
• Remission of Chronic Thrombotic Thrombocytopenic Purpura after Treatment with Cyclophosphamide and Rituximab

  2003cited by this paper
• ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions.

  2002cited by this paper
• ADAMTS13 and TTP

  2002cited by this paper
• Thrombotic microangiopathies.

  2002cited by this paper
• A Critical Role of Platelet Adhesion in the Initiation of Atherosclerotic Lesion Formation

  2002cited by this paper
• Localized reduction of atherosclerosis in von Willebrand factor-deficient mice.

  2001cited by this paper
• Structure of von Willebrand Factor-cleaving Protease (ADAMTS13), a Metalloprotease Involved in Thrombotic Thrombocytopenic Purpura*

  2001cited by this paper
• Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP.

  2000cited by this paper
• Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice.

  1999cited by this paper
• Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.

  1998cited by this paper
• Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion.

  1996cited by this paper
• L-selectin-deficient mice have impaired leukocyte recruitment into inflammatory sites

  1995cited by this paper
• Shear stress enhances the proteolysis of von Willebrand factor in normal plasma.

  1994cited by this paper
• Adenosine Nucleotides and Serotonin Stimulate von Wille-brand Factor Release from Cultured Human Endothelial Cells

  1994cited by this paper
• Epinephrine Augments von Willebrand Factor‐Dependent Shear‐Induced Platelet Aggregation

  1992cited by this paper
• Thrombotic microangiopathies.

  1991cited by this paper
• von Willebrand factor biosynthesis and partitioning between constitutive and regulated pathways of secretion after thrombin stimulation.

  1989cited by this paper
• Leukocyte-endothelial cell recognition: evidence of a common molecular mechanism shared by neutrophils, lymphocytes, and other leukocytes.

  1987cited by this paper
• Biosynthesis of von Willebrand protein by human endothelial cells: processing steps and their intracellular localization

  1984cited by this paper

• Immune-mediated thrombotic thrombocytopenic purpura as a model of systemic microvascular dysfunction: moving from an acute to a chronic disorder.

  2025cites this paper
• An Expendable Player in Positive Vascular Remodeling? ADAMTS13 Deficiency Does Not Affect Arteriogenesis or Angiogenesis

  2025cites this paper
• Association of Serum Thromboinflammatory Biomarkers With Atherosclerotic Plaques and Burden in a Community-Based Population.

  2025cites this paper
• The Highs and Lows of ADAMTS13 Activity

  2024cites this paper
• ECM Microenvironment in Vascular Homeostasis: New Targets for Atherosclerosis.

  2024cites this paper
• Association of ADAMTS13 activity with cerebral deep medullary vein: A community-based cross-sectional study

  2024cites this paper
• Coagulation Factor VIII Regulates von Willebrand Factor Homeostasis In Vivo.

  2023cites this paper
• Low Density Lipoprotein promotes Microvascular Thrombosis by enhancing von Willebrand Factor Self-association.

  2023cites this paper
• Immune thrombotic thrombocytopenic purpura: Spotlight on long-term outcomes and survivorship

  2023cites this paper
• To Gain Insights into the Pathophysiological Mechanisms of the Thrombo-Inflammatory Process in the Atherosclerotic Plaque

  2023cites this paper
• Cardiovascular Disease and Stroke in Immune TTP–Challenges and Opportunities

  2023cites this paper
• Thromboinflammation: From Atherosclerosis to COVID-19.

  2022cites this paper
• ADAM and ADAMTS disintegrin and metalloproteinases as major factors and molecular targets in vascular malfunction and disease.

  2022cites this paper
• Circulating ADAMTS13 Levels Are Associated with an Increased Occurrence of Obstructive Sleep Apnea

  2022cites this paper
• Constitutively active ADAMTS13: An emerging thrombolytic agent for acute ischemic stroke

  2022cites this paper
• Immune thrombotic thrombocytopenic purpura: pathogenesis and novel therapies: a narrative review

  2022cites this paper
• Animal models for thrombotic thrombocytopenic purpura: a narrative review

  2022cites this paper
• Role of CD40 ligand-mediated endothelial cell-monocyte interaction at atherosclerosis predilection sites.

  2022cites this paper
• The Relationship Between ADAMTS13 Activity and Overall Cerebral Small Vessel Disease Burden: A Cross-Sectional Study Based on CSVD

  2021cites this paper
• ADAMTS13 ameliorates inflammatory responses in experimental autoimmune encephalomyelitis

  2020cites this paper
• Von Willebrand Factor and ADAMTS13 and long-term outcomes in patients undergoing percutaneous coronary intervention.

  2020cites this paper
• Novel Mutation of Upshaw-Schulman Syndrome Associated with Coarctation of Aorta in Palestinian

  2020cites this paper
• Reduced ADAMTS13 activity during TTP remission is associated with stroke in TTP survivors.

  2019cites this paper
• Link between von Willebrand factor multimers, relapses and coronary microcirculation in patients with thrombotic thrombocytopenic purpura in remission.

  2019cites this paper
• Thrombotic microangiopathy as a cause of cardiovascular toxicity from the BCR-ABL1 tyrosine kinase inhibitor ponatinib.

  2019cites this paper
• Targeting von Willebrand Factor in Ischaemic Stroke: Focus on Clinical Evidence

  2018cites this paper
• Endothelial Cell–Derived Von Willebrand Factor, But Not Platelet-Derived, Promotes Atherosclerosis in Apolipoprotein E–Deficient Mice

  2018cites this paper
• Inflammation, von Willebrand factor, and ADAMTS13.

  2018cites this paper
• Shrunken Pore Syndrome Is Associated With Increased Levels of Atherosclerosis-Promoting Proteins

  2018cites this paper
• Tuning the endothelial response: differential release of exocytic cargos from Weibel‐Palade bodies

  2018cites this paper
• Platelets and von Willebrand factor in atherogenesis.

  2017cites this paper
• von Willebrand factor and its cleaving protease ADAMTS13 balance in coronary artery vessels: Lessons learned from thrombotic thrombocytopenic purpura. A narrative review.

  2017cites this paper
• Metalloproteinases in atherosclerosis

  2017cites this paper
• Reduced ADAMTS13 levels in patients with acute and chronic cerebrovascular disease

  2017cites this paper
• Chapter 2 Plasma ADAMTS 13 levels and the risk of myocardial infarction : an individual patient data meta-analysis

  2017influential citation
• High-density lipoprotein modulates thrombosis by preventing von Willebrand factor self-association and subsequent platelet adhesion.

  2016cites this paper
• Next-Generation Sequencing and In Vitro Expression Study of ADAMTS13 Single Nucleotide Variants in Deep Vein Thrombosis

  2016cites this paper
• Adamts13 -knockout mice

  2016cites this paper
• Von Willebrand Factor and ADAMTS13 in Cardiovascular Disease

  2016cites this paper
• THROMBOSIS AND HEMOSTASIS Human neutrophil peptides inhibit cleavage of von Willebrand factor by ADAMTS 13 : a potential link of in fl ammation to TTP

  2016cites this paper
• Human neutrophil peptides inhibit cleavage of von Willebrand factor by ADAMTS13: a potential link of inflammation to TTP.

  2016cites this paper
• Von Willebrand factor, ADAMTS13, and coronary microvascular obstruction: beautiful hypotheses, ugly facts.

  2016cites this paper
• Potential Clinical Use of Recombinant Human ADAMTS13

  2015cites this paper
• Unconjugated bilirubin inhibits proteolytic cleavage of von Willebrand factor by ADAMTS13 protease

  2015cites this paper
• ADAMTS13 deficiency in mice does not affect adipose tissue development.

  2015cites this paper
• Molecular Imaging of Platelet–Endothelial Interactions and Endothelial von Willebrand Factor in Early and Mid-Stage Atherosclerosis

  2015influential citation
• [Inhibitory effect of von Willebrand factor-cleaving protease on angiogenesis].

  2015cites this paper
• ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura.

  2015cites this paper
• The extracellular protease stl functions to inhibit migration of v'ch1 sensory neuron during Drosophila embryogenesis.

  2015cites this paper
• Low ADAMTS13 activity is associated with an increased risk of ischemic stroke.

  2015cites this paper
• Plasma ADAMTS‐13 levels and the risk of myocardial infarction: an individual patient data meta‐analysis

  2015cites this paper
• ADAMTS13: Structure and Function

  2015cites this paper
• Mechanism and functional impact of CD40 ligand-induced von Willebrand factor release from endothelial cells

  2015cites this paper
• 血管性血友病因子裂解酶对血管新生的抑制作用

  2015cites this paper
• Potential value of targeting von Willebrand factor in atherosclerotic cardiovascular disease

  2014cites this paper
• ADAMTS13 modulates atherosclerotic plaque progression in mice via a VWF‐dependent mechanism

  2014cites this paper
• Role of platelet CD40 ligand for endothelial cell-monocyte interaction in the presence of flow

  2014cites this paper
• Von Willebrand factor and ADAMTS13 in arterial thrombosis: a systematic review and meta-analysis.

  2014influential citation
• Structure–function and regulation of ADAMTS‐13 protease

  2013cites this paper
• Simvastatin increases ADAMTS13 expression in podocytes.

  2013cites this paper
• Animal models for thrombotic thrombocytopenic purpura

  2013cites this paper
• Structural and functional analysis of an ADAMTS13 mutant with the East Asian-specific P475S polymorphism

  2013cites this paper
• Endothelial Expression of Guidance Cues in Vessel Wall Homeostasis Dysregulation Under Proatherosclerotic Conditions

  2013cites this paper
• ADAMTS 13 deficiency exacerbates VWF-dependent acute myocardial ischemia / reperfusion injury in mice

  2012cites this paper
• ADAMTS13 deficiency exacerbates VWF-dependent acute myocardial ischemia/reperfusion injury in mice.

  2012cites this paper
• ADAMTS13, TTP and Beyond

  2012cites this paper